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Abstract
The diverse clinical phenotypes of Wolf–Hirschhorn syndrome
(WHS) are the result of haploinsufficiency of several genes, one of
which, LETM1, encodes a protein of the mitochondrial inner
membrane of uncertain function. Here, we show that LETM1 is
associated with mitochondrial ribosomes, is required for mitochon-
drial DNA distribution and expression, and regulates the activity of
an ancillary metabolic enzyme, pyruvate dehydrogenase. LETM1
deficiency in WHS alters mitochondrial morphology and DNA orga-
nization, as does substituting ketone bodies for glucose in control
cells. While this change in nutrient availability leads to the death
of fibroblasts with normal amounts of LETM1, WHS-derived fibrob-
lasts survive on ketone bodies, which can be attributed to their
reduced dependence on glucose oxidation. Thus, remodeling of
mitochondrial nucleoprotein complexes results from the inability
of mitochondria to use specific substrates for energy production
and is indicative of mitochondrial dysfunction. However, the
dysfunction could be mitigated by a modified diet—for WHS, one
high in lipids and low in carbohydrates.
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Introduction
Mitochondria are major contributors to cellular energy production,
converting nutrients to ATP through the oxidative phosphorylation
system (OXPHOS). Thirteen essential proteins of OXPHOS are
transcribed from mitochondrial DNA (mtDNA) and synthesized by
the mitochondrial ribosomes (mitoribosomes), via a highly special-
ized system that is tightly coupled to the inner mitochondrial
membrane (IMM; Liu & Spremulli, 2000). In yeasts, the proposed
machinery of co-translational membrane insertion includes Oxa1,
mba1, and mdm38 (Ott & Herrmann, 2010). Mdm38 is an integral
inner membrane protein conserved among eukaryotes, and it is
suggested to play a role in multiple facets of mitochondrial metabo-
lism, the precise nature of which remains unclear. Under certain
conditions, it co-fractionates with the mitoribosome, on buoyant
density gradients (Frazier et al, 2006; Kehrein et al, 2015), and it is
proposed to regulate mitochondrial translation (Bauerschmitt et al,
2010). Furthermore, mdm38 regulates mitochondrial morphology
and volume by controlling ion homeostasis across the mitochondrial
inner membrane (Nowikovsky et al, 2004, 2007; Froschauer et al,
2005).
The human mdm38 homolog, LETM1, is inferred to regulate
mitochondrial volume in a similar way to its yeast counterpart, as
its ablation results in swollen mitochondria (Dimmer et al, 2002,
2008; Hasegawa & van der Bliek, 2007; Tamai et al, 2008; Jiang
et al, 2009; McQuibban et al, 2010), whereas elevated expression
produces condensed mitochondria with compact cristae (Hasegawa
& van der Bliek, 2007). Whether monoallelic LETM1 deletion results
in mitochondrial dysfunction is still uncertain, as some studies
described an alteration of the assembly of the respiratory chain
supercomplexes (Tamai et al, 2008), while others reported no
evident mitochondrial dysfunction or link with the mitochondrial
ribosomal machinery (Dimmer et al, 2008).
LETM1 is often deleted in Wolf–Hirschhorn syndrome (WHS;
Zollino et al, 2003), a disorder caused by deletions of the short arm
of one chromosome 4, encompassing multiple genes. Although
LETM1 levels are consistently decreased in fibroblasts and
lymphoblastoid cell lines of WHS patients harboring LETM1 dele-
tions (Hasegawa & van der Bliek, 2007; Dimmer et al, 2008; Doonan
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et al, 2014; Hart et al, 2014), only modest alterations of mitochon-
drial membrane potential and free radical production have been
reported (Doonan et al, 2014; Hart et al, 2014). Moreover, mice
with a single copy of Letm1 appear normal, with none of the facial
or midline developmental defects typical of WHS LETM1-deficient
patients. However, pyruvate dehydrogenase (PDH) activity was
decreased in the brain of fasted Letm1+/ mice, suggesting a role
for the protein in glucose metabolism (Jiang et al, 2013). The uncer-
tainty surrounding LETM1 has left a gap in our understanding of the
role of LETM1 protein both in mitochondrial biology and in its clini-
cal relevance to WHS. Therefore, we set out to address several of
the outstanding questions: of the role of LETM1 in mitochondrial
gene expression in mammals; whether mitochondrial dysfunction in
WHS is attributable to LETM1 haploinsufficiency; and whether the
effect on glucose metabolism in humans is comparable to the
Letm1+/ mouse (Jiang et al, 2013). Analysis of the form and func-
tion of mitochondria in WHS patient-derived fibroblasts and LETM1
gene-silenced cells indicates that LETM1 couples pyruvate oxidation
to mtDNA metabolism, and that LETM1 deficiency in WHS results
in mitochondrial dysfunction that exacerbates the disorder.
Results
LETM1 is required for mitochondrial translation and respiration
in mammalian cells
Findings from yeasts suggest that the LETM1 homolog, mdm38,
facilitates the translation and assembly of specific mitochondrial
proteins into respiratory chain complexes (Bauerschmitt et al,
2010). To address whether LETM1 contributed to mitochondrial
protein synthesis (MPS) in mammals, we repressed its expression in
HeLa cells via RNA interference. All three siRNAs targeting LETM1
[siR1, siR2, or siR3 (Appendix Fig S1A)] caused mitochondrial swel-
ling (Fig 1A), as previously reported (Dimmer et al, 2002, 2008;
Hasegawa & van der Bliek, 2007; Tamai et al, 2008; Jiang et al,
2009; McQuibban et al, 2010), and each siRNA impaired MPS
(Fig 1B and C; and Appendix Fig S1B) albeit to different extents.
The marked decrease in LETM1 protein induced by siR1 or siR3
produced a more severe impairment of mitochondrial translation
than siR2, which was associated with more residual protein (Fig 1B
and C). The steady-state level of selected OXPHOS subunits was also
directly proportional to the amount of LETM1 (Fig 1D), and the
largest decreases in respiratory capacity were associated with the
most pronounced reduction in LETM1 expression (Fig 1E). Thus,
LETM1 deficiency impairs mitochondrial translation and restricts
respiratory capacity in mammalian cells in a dose-dependent
manner.
LETM1 depletion compromises 55S ribosome maintenance and
alters the levels and distribution of mtDNA and mtRNA
To determine the effect of LETM1 depletion on the mitochondrial
ribosome, the abundance of selected mitochondrial ribosomal
polypeptides and ribosomal RNAs was determined after LETM1
knockdown. LETM1 silencing decreased the levels of structural
components of both mitoribosome subunits, MRPS17 and MRPL11,
and the assembly factor C7orf30 (Rorbach et al, 2012; Wanschers
et al, 2012; Fig 2A and Appendix Fig S1C), as well as the 12S and
16S ribosomal RNAs (Fig 2B). Furthermore, when lysates were frac-
tionated on sucrose gradients the 55S ribosome was significantly
decreased in cells partially depleted of LETM1, with a concomitant
increase in the proportion of mitoribosome components at the top of
the gradient (Fig 2C). These data suggest that LETM1 is required for
55S ribosome assembly or stability.
Mitochondrial transcription supplies the messenger and riboso-
mal RNAs for protein synthesis, and ribosomal (small subunit)
assembly has been proposed to occur at the mitochondrial nucleoid
(He et al, 2012a; Bogenhagen et al, 2014; Dalla Rosa et al, 2014).
Moreover, RNA processing and ribosome assembly involve a suite
of factors organized in RNA granules in close proximity to the
mtDNA, including GRSF1 (Antonicka et al, 2013; Jourdain et al,
2013; Tu & Barrientos, 2015). Hence, mitoribosome dysfunction
could be the cause or the consequence of aberrant mtRNA and
mtDNA metabolism. Therefore, we next determined the effects of
LETM1 depletion on the mitochondrial RNA and DNA levels.
LETM1 deficiency consistently increased mtDNA copy number
(Fig 2D), whereas it reduced the mitochondrial transcript
▸Figure 1. LETM1 is required for mitochondrial translation and respiration.A Immunofluorescence analysis of HeLa cells transfected with either a non-target dsRNA (NT) or one of the three siRNAs targeting LETM1 (siR1, siR2, or siR3) and
labeled with anti-TOM20 antibody. In siR1-treated cells, the mitochondria formed a “honeycomb” of swollen distinct organelles; siR3 resulted in giant organelles with
a central region distinguished by reduced TOM20; siR2 produced relatively little swelling, and the mitochondrial network was generally well preserved. The
pronounced swelling induced by siR1 significantly increased circularity (P = 2.32E-58; ImageJ analysis), siR1 circularity = 0.683  0.012 compared with
0.414  0.008 for the NT, where 1 = a perfect circle. Over 150 mitochondria were quantified in each cell type; data are mean  SEM. Scale bar represents 12 lm in
the main images and 4 lm in offset magnification.
B 35S labeling of de novo mitochondrial protein synthesis of HeLa cells transfected as in (A). Polypeptide assignments flank the gel images. Coomassie-stained gels are
used as loading controls, and immunoblots indicate the efficiency of LETM1 knockdown.
C Quantification of the radiolabeled mitochondrial polypeptides in panel (B) and similar gels, expressed relative to protein synthesis of the NT. Data are expressed as
mean  SEM of n = 6 independent experiments; 1 or 2 rounds of transfection for siR1 and siR3, but exclusively 2 rounds in the case of siR2.
D Representative immunoblots for the OXPHOS proteins NDUFB8 and COII of HeLa cells transfected with NT or siLETM1 (siR1, siR2, or siR3). Vinculin and GAPDH are
shown as loading controls. The mean relative abundances for respiratory subunits COII and NDUFB8 are shown beneath the blots. Data are expressed as
mean  SEM of n = 8 independent experiments.
E Mitochondrial oxygen consumption rate (OCR) measured using a Seahorse flux analyzer before (basal) and after the addition (maximal) of the uncoupler FCCP, in
HeLa cells treated with NT or siLETM1 (siR1 or siR2). Data are expressed as mean  SEM of n = 5 independent experiments.
Data information: Unpaired t-test (panel A) and one-way ANOVA in panels (B–E). P-values < 0.05 were considered to be statistically significant and labeled as follows:
*P < 0.05, **P < 0.01, and ***P < 0.001. ns, not statistically significant.
Source data are available online for this figure.
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abundance per mtDNA (Fig 2E and Appendix Fig S1D). The highest
mtDNA copy number, 2.6 times that of controls with siR3, was
accompanied by transcript levels similar to controls, while the more
modest 1.5-fold increase in mtDNAs induced by siR1 was associated
with significantly reduced mRNA levels (Fig 2D and E). Thus,
LETM1 deficiency impairs mitochondrial transcription, compen-
sated, fully in the case of siR3, by elevated mtDNA copy number.
In light of the perturbations to mitochondrial DNA and RNA
levels (Fig 2D and E), we next determined the effects of LETM1
silencing on mtDNA and RNA form and distribution. All three
siRNAs targeting LETM1 produced mtDNA alterations (Figs 3A and
B, and EV1A; and Appendix Fig S2), characterized by an increase in
the size of many mtDNA foci (in the case of siR1; Fig 3A-ii) or by
clustering of mtDNA (siR3 and siR2), the extent of which, again,
correlated with the level of LETM1 protein (Figs 3A-iii, 4A-iv, and
EV1A; and Appendix Fig S2). Similarly, the foci formed by newly
synthesized RNA and an RNA granule protein, GRSF1, were aberrant
in size and distribution in LETM1-deficient cells (Fig 3C and D).
A fraction of LETM1 associates with mitochondrial
nucleoprotein complexes
To determine whether the phenotypes associated with LETM1
depletion reflected a direct interaction with the nucleic acids or ribo-
somes, we first assessed the pattern of LETM1 distribution in mito-
chondria. Immunofluorescence analysis of endogenous LETM1
indicated that the protein did not form the punctate patterns of
either mitochondrial nucleoids (Spelbrink, 2010; Fig 4A) or newly
synthesized RNA or GRSF1 (Antonicka et al, 2013; Jourdain et al,
2013; Tu & Barrientos, 2015; Fig EV1B), and was instead
distributed throughout the mitochondrial network, comparable to
mitochondrial ribosomes, and the outer mitochondrial membrane
protein TOM20 (Figs 4B and EV1B). Hence, immunofluorescence
lacked the resolution to determine whether LETM1 physically inter-
acts with the mitoribosome; therefore, we next fractionated mito-
chondrial lysates on two types of density gradient. Mitochondrial
ribosomes and nucleoids cluster in one or two fractions on iodixanol
gradients, well separated from the majority of mitochondrial
proteins (He et al, 2012b), and a portion of LETM1 co-fractionated
with these nucleoprotein complexes (Fig 4C). LETM1 also co-affi-
nity purified with mitochondrial DNA interacting proteins in a
recent study (Matic et al, 2018). For the specific analysis of mito-
chondrial ribosomes via sucrose gradient sedimentation, different
salt concentrations were tested, since it has been proposed that the
interaction of the yeast mdm38 with ribosomes is a function of the
ionic strength (Kehrein et al, 2015). The 55S mitochondrial ribo-
some of cultured cells readily dissociates into its constituent 28S
and 39S subunits on sucrose gradients; nevertheless, the small
amount of intact 55S ribosomes co-migrated with a fraction of the
LETM1 protein when mitochondrial lysates were separated using a
50 mM, but not 100 mM NaCl buffer (Fig 4D). These findings
suggest that LETM1 physically interacts with the human mitochon-
drial ribosome, which can include interaction with mRNA (activa-
tors), as has been proposed for the yeast homolog (Bauerschmitt
et al, 2010). The effects of LETM1 deficiency on mitochondrial DNA
and RNA as well as the 55S ribosome fit with the protein facilitating
ribosome assembly, which occurs at the nucleoid (He et al, 2012a;
Bogenhagen et al, 2014; Dalla Rosa et al, 2014) and closely associ-
ated RNA granules (Antonicka et al, 2013; Jourdain et al, 2013; Tu
& Barrientos, 2015). On the other hand, yeast mitochondrial ribo-
somes and nucleoids are interconnected (Kehrein et al, 2015) and
co-purification analysis is consistent with a similar arrangement in
human mitochondria (Rorbach et al, 2008; He et al, 2012b). Thus,
LETM1 deficiency could primarily disturb the connections between
◀ Figure 2. LETM1 depletion compromises mitochondrial ribosome maintenance and alters the abundance of mitochondrial DNA and RNAs.A Steady-state levels of mitochondrial ribosomal structural subunits (MRPL11 and MRPS17) or assembly factor (C7orf30) of HeLa cells transfected with siRNAs for either
NT or LETM1 (siR1, siR2, or siR3). Vinculin and GAPDH are shown as loading controls. Data are expressed as mean  SEM of n = 3 independent experiments for siR1
and siR2, and n = 2 (MRPL11) or 1 (MRPS17 and C7orf30) for siR3.
B Relative 12S (upper panel) and 16S rRNA (lower panel) levels in HeLa cells after LETM1 siRNA compared to NT, n = 3 independent experiments.
C Total lysates from HeLa cells treated with NT or a siRNA for LETM1 were separated on 100 mM NaCl, 10–30% isokinetic sucrose gradients, and fractions analyzed by
immunoblotting with antibodies to components of the large (39S) and small (28S) subunit of the 55S ribosome. Immunoblots were quantified by ImageJ, and the
value for each fraction was expressed as a percentage of the sum of all fractions. Data are expressed as mean  SEM of n = 3 independent experiments.
D Relative mtDNA copy number estimated by qPCR. Data are expressed as mean  SEM of n = 3 independent experiments except for siR3 (n = 2).
E The combined average mRNA levels of ND1, COII, COIII, Cyt b, and ATP6/8 in HeLa cells treated with either NT or siLETM1 (siR1, siR2, or siR3). Data are mean
values  SEM of n = 3 independent experiments.
Data information: One-way ANOVA in panels (A, B, D, and E); Unpaired t-test with Welch’s correction in panel (C). P-values < 0.05 are considered to be statistically
significant and labeled as follows: *P < 0.05, **P < 0.01, and ***P < 0.001. ns, not statistically significant.
Source data are available online for this figure.
▸Figure 3. LETM1 repression perturbs mtDNA and mtRNA organization.A LETM1 expression was suppressed in HeLa cells by transfection with targeted siRNAs (siR1, siR2, or siR3). A non-target dsRNA (NT) served as control. Cells were fixed
and immunolabeled with anti-DNA antibody (green). A higher magnification of selected mtDNA foci is shown beside each picture.
B Quantification of cells in (A) displaying mtDNA abnormalities. At least 50 cells per siRNA were counted from 4 (siR2) and 5 (siR1 or siR3) independent experiments.
Data are expressed as mean  SEM. ***P < 0.001 (one-way ANOVA).
C HeLa cells were labeled with bromouridine (BrU) for 60 mins, 144 h after transfection with NT or siR2, and stained with anti-BrdU (green) and anti-GRSF1 (red)
antibodies. Cell nuclei were stained with DAPI (blue).
D HeLa cells were labeled with anti-DNA (green) and anti-GRSF1 (red) antibodies, 144 h after transfection with NT or siR3. Cell nuclei were stained blue with DAPI.
Data information: Scale bars represent 12 lm in the main images and 4 lm in offset magnifications.
Source data are available online for this figure.
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mitochondrial nucleoids and ribosomes resulting in impaired ribo-
some maintenance and protein synthesis, when severe. Whatever
the details of the interdependence of mtDNA organization and
expression, the findings for LETM1 suggest that insufficiency or
defects in many components of mitochondrial nucleoids or the mito-
chondrial translation machinery could produce similar phenotypes;
indeed, MPV17L2 depletion causes marked mtDNA aggregation and
severe ribosome maintenance defects (Dalla Rosa et al, 2014), and a
mutation in the aminoacyl tRNA synthetase, FARS2, causes mtDNA
aggregation (Almalki et al, 2014).
Decreased DRP1 activity mitigates the effects of reduced
expression of LETM1
We next examined the mitochondrial fission factor DRP1 in the
LETM1-deficient cells, because its repression is known to cause
mtDNA clustering (Ban-Ishihara et al, 2013). Transfection of HeLa
cells with siR1 increased the abundance of the active phosphory-
lated form of DRP1 (DRP1S616; Fig 5A and Appendix Fig S3A),
whereas the two LETM1 siRNAs (siR2 and siR3) associated with
mtDNA clustering had decreased levels of (active) DRP1 protein
(Fig 5A). Therefore, the mtDNA clustering associated with LETM1
silencing might be dependent on DRP1 repression. Moreover, since
siR1 produced the most severe impairment of mitochondrial transla-
tion, repressing DRP1 when LETM1 is scarce might improve mtDNA
expression. Concordant with the latter idea, co-silencing of DRP1
and LETM1 attenuated the effects of LETM1 silencing alone (siR1),
both in respect of MPS and the steady-state level of selected respira-
tory chain components (Fig 5B and C; and Appendix Fig S3B). As
well as enhancing the expression of OXPHOS complexes, the dual
gene silencing altered the mtDNA, producing a phenotype
intermediate between that of either DRP1 or LETM1 repression alone
(Fig 5D). Hence, silencing of LETM1 and DRP1 has different, possi-
bly opposing, effects on mtDNA organization, which could explain
the benefit of co-repressing DRP1 when there is a shortage of
LETM1, as occurred spontaneously with siR3 (and on occasion
siR2) targeting LETM1 (Figs 3 and EV1A; and Appendix Fig S2) and
in the context of WHS (see below).
Loss of one allele of LETM1 is associated with mitochondrial
swelling and mtDNA clustering
The defined mitochondrial phenotypes caused by LETM1 deficiency
in HeLa cells provided points of reference to assess the conse-
quences of LETM1 haploinsufficiency in WHS. Mitochondrial meta-
bolism was investigated in primary fibroblasts of four subjects with
a monoallelic deletion on the short arm of chromosome 4 encom-
passing LETM1 (S1–S4, LETM1+/), each of whom presented with
typical WHS features and epilepsy (Appendix Table S1 and
Appendix Fig S4). Fibroblasts of a fifth subject, S5 (the mother of
S3), whose deletion did not include LETM1 (thus LETM1+/+), were
analyzed in parallel. Cells of S1–S4 expressed approximately half as
much LETM1 protein as control cells or those of S5 (Figs 6A and
EV2A). Hence, LETM1 haploinsufficiency is associated with reduced
expression of LETM1 protein in WHS fibroblasts, whereas the adja-
cent genes deleted in subject S5 had no impact on the expression of
LETM1 (Appendix Fig S4). However, with this amount of residual
LETM1 protein, mitochondrial abnormalities were expected to be at
the milder end of the spectrum observed in HeLa cells silenced for
LETM1. Accordingly, there was no appreciable impairment of mito-
chondrial translation (Appendix Fig S5A), and there was little or no
decrease in respiratory chain components in WHS fibroblasts
◀ Figure 4. LETM1 co-fractionates with mitochondrial nucleoprotein complexes and is widely distributed in the mitochondrial network, like ribosomes andunlike mtDNA.
A, B HeLa cells were immunostained with anti-DNA (green) and anti-LETM1 (red) (A), or anti-LETM1 (green) and anti-MRPS18 (red) (B).
C Mitochondrial lysates from HEK293T cells were fractionated on 20–42.5% iodixanol gradients and the migration patterns of LETM1 and selected nucleoid
components determined by immunoblotting.
D HeLa mitochondrial lysates were fractionated on 10–30% sucrose gradients, and the distribution of LETM1 and ribosomal proteins was determined by
immunoblotting. 55S corresponds to the assembled mitoribosome and 28S and 39S to its small and large subunits, respectively. Mitochondria were lysed in 100 or
50 mM NaCl (top and bottom panels, respectively).
Data information: Scale bars are 12 lm in the main images and 3 lm in offset magnifications.
Source data are available online for this figure.
▸Figure 5. Changes to DRP1 in response to LETM1 depletion.§A Representative immunoblots of LETM1, DRP1 total protein levels, and activating phosphorylation (DRP1S616) in HeLa cells treated with either NT or LETM1 siR1, siR2,
or siR3. GADPH is shown as a loading control. Immunoblot signals were quantified using ImageJ; data are displayed as mean  SEM of n = 4 independent
experiments except for siR3 DRP1S616 (n = 2).
B One hour 35S pulse-labeling of mitochondrial translated proteins in HeLa cells silenced for LETM1 (siR1) or DRP1 (siD), or co-silenced for LETM1 and DRP1 (siR1D) for
144 h. Coomassie-stained gels are used as loading controls, and polypeptide assignments are indicated to the right.
C Immunoblotting of cell lysates prepared as in (B) with antibodies to respiratory chain subunits NDUFB8 and COII, and GAPDH as loading control. Data are expressed
as mean  SEM of n = 3 independent experiments.
D Confocal analysis of HeLa cells silenced for LETM1 (siR1), or for DRP1 (siD), or co-silenced with both siR1 and siD for 96 h. Mitochondrial network, mtDNA, and cell
nuclei were immunostained with anti-TOM20 (red) anti-DNA (green), and DAPI (blue), respectively. Scale bars are 6 lm in the main images and 3 lm in offset
merged magnifications.
Data information: One-way ANOVA in panels (A and C). *P < 0.05, **P < 0.01, ***P < 0.001. ns, not statistically significant.
Source data are available online for this figure.
§Correction added online on 2 August 2018 after first online publication: the labels “siD” and “siR1+siD” in Figure 5D have been corrected.
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(Appendix Fig S5B); nevertheless, there were mitochondrial pertur-
bations. Confocal microscopy revealed abnormal mitochondrial
morphology in all the WHS cell lines lacking one copy of LETM1,
and many mitochondria were more elongated than those of control
cells and S5 (Appendix Fig S6A) and had numerous distensions
(Fig 6B), while the largest mitochondria were often separated from
the main network (Fig 6B zoom), suggesting that the swellings
caused the mitochondrial network to fragment in places.
The abnormal mitochondrial morphology reported here was
marked and not reported in previous studies of WHS fibroblasts
(Hasegawa & van der Bliek, 2007; Dimmer et al, 2008; Doonan et al,
2014); therefore, we further analyzed mitochondrial ultrastructure
in WHS fibroblasts by transmission electron microscopy. Fibroblasts
from three controls (C1–C3) and subject S5 contained mitochondria
of normal appearance (Figs 6C and EV2C). In contrast, approxi-
mately 70% of mitochondria of the LETM1+/ WHS patients were
branched, thinned, and elongated (Fig 6D); frequently, the cristae
were scarce and the remainder were rounded in shape (Figs 6D and
EV2B–D), while the mitochondrial matrix in organelles where
cristae were present appeared dense and more compact than normal
(Fig EV2C). Hence, the loss of one allele of LETM1 in fibroblasts of
WHS subjects is associated with mitochondrial morphology abnor-
malities based on light and electron microscopy.
The distended and swollen mitochondria of the LETM1-deficient
WHS fibroblasts displayed mtDNA clustering (Fig 7A and B; and
Appendix Fig S6B) in a significantly greater proportion of cells than
controls or subject S5 (Fig 7C), and this was associated with
elevated mtDNA copy number in the cell lines tested (S1 and S4;
Fig 7D). DRP1 was decreased in all cells of LETM1-deficient WHS
subjects compared to controls, especially the active form of the
protein (Fig 7E), which can account for the elongated mitochondria
(Appendix Fig S6A). This finding strengthens the earlier conclusion
that the repression of DRP1 is a frequent consequence of LETM1
deficiency that causes mtDNA clustering, and the data from HeLa
cells suggest that it is a compensatory mechanism that limits the
adverse effects of a shortage of LETM1 (Fig 5). Although the repres-
sion of DRP1 was associated with elongated mitochondria, there
were also many discrete swollen mitochondria in the WHS cells
(Fig 6B) suggesting that LETM1 deficiency causes partial fragmenta-
tion of the mitochondrial network in a DRP1-independent manner,
as previously proposed (Dimmer et al, 2008). Taken together, these
features indicate that WHS fibroblasts lacking one LETM1 allele
recapitulate features of synthetic LETM1 deficiency in HeLa cells,
including aberrant mitochondrial morphology, mtDNA disorganiza-
tion, and elevated copy number.
WHS patient fibroblasts remodel their metabolism away from
pyruvate oxidation toward ketone body utilization
Mitochondrial morphology and dynamics are altered in response to
a number of stimuli, including nutrient deprivation, and it has been
proposed that changes in mitochondrial dynamics remodel substrate
utilization for bioenergetic purposes (Buck et al, 2016; Wai &
Langer, 2016). Hence, the mitochondrial morphology of the WHS
fibroblasts lacking one LETM1 allele might be indicative of a nutri-
ent-restricted state, or increased reliance on substrates other than
glucose. Moreover, the brain of Letm1 heterozygous mice, under
fasted conditions, displays a reduction in pyruvate dehydrogenase
(PDH) activity (Jiang et al, 2013), which is critical for pyruvate
utilization by mitochondria. Thus, we judged the regulation of PDH
to be a prime potential function of LETM1. Analysis of iodixanol
gradients of HEK cells indicated that almost all of the PDH-E1
subunit co-fractionated with mitochondrial nucleoprotein complexes
(Fig 8A), consistent with its partner subunit (E2) being highly
enriched in preparations of amphibian mtDNA (Bogenhagen et al,
2003), and its co-purification with mtDNA binding proteins and
many components of the mitochondrial translation apparatus of
HeLa cells (Matic et al, 2018). The inactive phosphorylated form of
PDH-E1 was more abundant in WHS fibroblasts than in controls
when cultured in 25 mM glucose and 1 mM pyruvate (Fig 8B and
▸Figure 7. WHS LETM1+/ fibroblasts display increased mtDNA copy number and mtDNA clusters.A Confocal analysis of control C2, WHS LETM1+/ S4, and WHS LETM1+/+ S5 cells, immunolabeled with anti-TOM20 (red), DNA (green), and DAPI (blue). Scale bar: 8 lm.
B Confocal images of control C1 and WHS LETM1+/ S3 labeled with TOM20, DNA, and DAPI, shown as merge. Scale bar: 8 lm.
C Quantification of cells in (A) displaying mtDNA aggregates. At least 50 cells per cell line were counted from three independent experiments. Data are expressed as
mean  SEM.
D qPCR quantified mtDNA copy number in WHS and control cells. Values are expressed relative to control cells (C1–C3). Data are expressed as mean  SEM of n = 3
independent experiments.
E Relative abundance of DRP1 and DRP1S616 in whole-cell extracts of control and WHS fibroblasts, with GAPDH shown as a loading control. Immunoblot signals were
quantified using ImageJ, and data are expressed as mean  SEM of n = 5 independent experiments.
Data information: One-way ANOVA in panels (C–E). **P < 0.01, ***P < 0.001. ns, not statistically significant.
Source data are available online for this figure.
◀ Figure 6. LETM1 haploinsufficiency in WHS is associated with abnormal mitochondrial morphology and ultrastructure.A Steady-state levels of LETM1 protein in fibroblasts from controls (C1–C3), WHS LETM1+/ (S1, S3, S4), and S5, the sole case of WHS in this study whose deletion does
not encompass LETM1 (boxed in blue). GAPDH is shown as a loading control.
B Immunofluorescence analysis of control (C1), WHS LETM1+/ S1-S4, and fibroblasts with anti-TOM20 antibody. Scale bars are 8 lm in the main images and 3 lm in
offset merged magnifications.
C Electron micrographs of controls (C1 and C2) and WHS LETM1+/+ (S5) cells; side panels show zooms. Scale bar: 0.2 lm. Black arrows indicate the areas shown offset at
higher magnification.
D Electron micrographs of WHS LETM1+/ S1, S3, and S4 cells. Black arrows indicate elongated and branched mitochondria; side panels show magnifications. Scale bar:
0.2 lm.
Source data are available online for this figure.
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C), which can be attributed to LETM1 deficiency, as phosphorylated
PDH-E1 was also elevated in LETM1 repressed HeLa cells
(Appendix Fig S7). Commensurate with the increased phosphoryla-
tion of PDH-E1, WHS fibroblasts had elevated PDH kinase 3 (PDK3;
Figs 8B and EV3A), which targets the E1 subunit (Kolobova et al,
2001; Zhang et al, 2014). These results imply that pyruvate oxida-
tion is low in WHS fibroblasts compared to control cells, and thus,
WHS mitochondria might be configured to utilize carbon sources
other than glucose, such as fatty acids or ketone bodies. In support
of this interpretation, fibroblasts cultured in medium containing the
ketone body b-hydroxybutyrate (BHB) in place of glucose, suffered
a “metabolic crisis” that led to extensive cell death, from which the
fibroblasts of four healthy controls and subject S5 failed to recover,
while the cells of all four (LETM1+/) WHS subjects continued to
divide even after passaging (Figs 8C and EV3B; Appendix Fig S8;
Movies EV1 and EV2).
Nutrient availability alters mtDNA organization and expression
The changes in mtDNA organization and nutrient utilization
resulting from LETM1 deficiency suggested that the two might
be linked. Therefore, the effect on mtDNA distribution of replac-
ing glucose and pyruvate with ketone bodies (KB) was assessed.
The number of control fibroblasts with mtDNA aggregates
increased sixfold within 24 h of switching to BHB (Fig 8D and
E) and remained at this level until the cells died (Fig 8C and E-
i). Replacement of glucose and pyruvate with KB further
increased the number of WHS LETM1+/ fibroblasts displaying
mtDNA clustering to a peak of 85% of all the cells after 56 h
(Fig 8E-ii); however, this subsided close to the original level by
99 h and continued to fall thereafter, such that, after 3 weeks of
the KB regime, mtDNA organization and distribution appeared
similar to control cells (Appendix Fig S9). To further test the
link between nutrients and mtDNA aggregation, we cultured
control fibroblasts in 5 mM glucose and 0.3 mM BHB with or
without 1 mM pyruvate. Neither decreasing the glucose concen-
tration from 25 to 5 mM, nor supplementing the medium with
ketone bodies markedly altered mtDNA organization, whereas
the withdrawal of pyruvate induced mtDNA clustering in cells to
a similar extent as glucose and pyruvate replacement with KB
(Fig 9A). Moreover, the mitochondrial translation impairment
induced by LETM1 deficiency is influenced by nutrients, as the
replacement of glucose with KB (BHB or acetoacetate) increased
the amount of newly synthesized mitochondrial protein in HeLa
cells depleted of LETM1 compared to the same cells grown in
25 mM glucose and 1 mM pyruvate (Fig 9B). These findings
indicate that mtDNA organization, distribution, and expression
are influenced directly by nutrient availability.
◀ Figure 8. WHS LETM1+/ fibroblasts show reduced PDH phosphorylation and tolerate a strict ketogenic diet.A Representative immunoblots of mitochondrial lysates of HEK cells separated on a 20–42.5% iodixanol gradients probed for LETM1, TFAM, and PDH.
B Left panel: immunoblot analysis of total PDH protein levels and the inactive phosphorylated (repressed form) PDHS293, in control (C1, C3), WHS LETM1+/ (S1, S3, S4),
and WHS LETM1+/+ (S5) fibroblasts. Center and right panels: Immunoblot analysis of PDK3 in control (C1–C3), WHS LETM1+/ (S1, S3, and S4), and WHS LETM1+/+ (S5)
fibroblasts.
C Left panel: change in cell confluence of control (C1–C3), WHS LETM1+/ (S1-S4), and WHS LETM1+/+ (S5) fibroblasts grown in BHB over the course of 188 h. Data are
expressed as mean  SEM of n = 3 independent experiments. Right panel: images of control and WHS LETM1+/ S4 cells growing either in the presence of 25 mM
glucose (HG) or BHB (KB) for 6 days.
D Confocal images of control cells (C1) grown for 24 h in the presence of BHB and immunolabeled with anti-TOM20 (red) and anti-DNA (green), and DAPI-stained
(blue). Scale bar 6 lm.
E Proportion of cells that displayed mtDNA aggregation during the KB treatment (panel i—control cells (C1, C2) and WHS LETM1+/+ (S5) fibroblasts; panel ii—LETM1+/
(S1, S2, S4) fibroblasts). At least 50 cells per cell line were counted at the indicated time points. Data are expressed as mean  SEM of n = 3 independent
experiments.
Source data are available online for this figure.
▸Figure 9. Mitochondrial DNA re-organization in response to nutrient changes.A Proportion of mtDNA cluster following 48 or 96 h of growth in medium with (+) or without () 25 mM glucose (HG), 5 mM glucose (LG), b-hydroxybutyrate (BHB), or
1 mM pyruvate (pyr). At least 50 cells per cell line were counted per condition from two independent experiments. Data are expressed as mean  SEM.
Representative images appear below the charts. Scale bar: 15 lm.
B 35S labeling of de novo mitochondrial protein synthesis for 1 h, 72 h after transfection of HeLa cells with either a non-target dsRNA (NT) or LETM1 siR1; KBs (0.1 mM
BHB or acetoacetate (AA)) replaced HG (25 mM glucose, 1 mM pyruvate) 9 h before the labeling reaction. Polypeptide assignments flank the gel image; Coomassie-
stained gels are used as loading controls, and immunoblots indicate the efficiency of LETM1 knockdown.
C Perceived or actual nutrient availability alters the organization of mitochondrial nucleoprotein complexes. In yeasts, mitochondrial ribosomes are physically linked to
mitochondrial nucleoids (Kehrein et al, 2015), and purification studies of a mitochondrial ribosomal protein (Rorbach et al, 2008) and mitochondrial nucleoid proteins
(He et al, 2012a) suggest that the same is true of mammalian mitochondria, as illustrated in (a). The current study indicates that changes in nutrient availability (a
switch from glucose to ketone body supplemented culture medium) lead to re-organization of mitochondrial nucleoprotein complexes (MNPCs; panel A and Fig 8D
and E, and illustrated in (b)). We infer that MNPC disorganization in LETM1 deficiency is the result of a failure to utilize pyruvate—a defect in nutrient sensing—that
can be attributed to repression of pyruvate dehydrogenase (PDH) via PDK3 (Figs 8B and EV3A). Because the bulk of PDH appears to be physically associated with
MNPC (Fig 8A), this could be mediated by the LETM1 bound to mitochondrial ribosomes/MNPC (Fig 4C). The direct and marked impact of nutrients on MNPCs is
further evidenced by the adaptation of WHS cells (LETM1+/) to KBs (Figs 8E-ii and EV3; and Appendix Figs S8 and S9), and the demonstration that KBs mitigate the
mitochondrial translation impairment caused by LETM1 depletion (Fig 9B). Hence, WHS cells progressively adapt mtDNA organization to the alternative carbon
source (c), whereas control cells are not primed for KB utilization, and in their case, MNPC clustering is followed by cell death (d) (Fig 8C and Movie EV1).
Source data are available online for this figure.
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Discussion
There has been considerable debate as to the roles of LETM1 in
mitochondrial metabolism, the resolution of which was needed to
assess its possible contribution to the pathogenesis of WHS. Here,
we demonstrate that mitochondrial abnormalities are evident in
primary cells of WHS subjects lacking one allele of LETM1 and that
reduced LETM1 expression is associated with the remodeling of
nutrient metabolism in a disease state. Although WHS deletions
involve a number of other genes, the loss of which could contribute
to the metabolic and mitochondrial phenotypes, the mitochondrial
phenotypes were exclusive to the WHS cells lacking a LETM1 allele
and were evident in HeLa cells after LETM1 silencing. Moreover,
altered glucose and pyruvate metabolism are features of Letm1+/
mice, where no other gene is mutated (Jiang et al, 2013). Therefore,
we conclude that when LETM1 is scarce, there is a switch to the
consumption of ketone bodies, even in the presence of high levels
of glucose, and that the decreased reliance of WHS fibroblasts on
glucose and pyruvate primes them to survive growth supported on
ketone bodies (Figs 8 and EV3B; Appendix Figs S8 and S9; and
Movie EV2). The inference that LETM1 promotes the oxidation of
glucose over lipid and amino acid catabolism has potentially impor-
tant clinical implications: WHS patients could benefit from a strict
diet comprising high lipid and proteins with low carbohydrate and
sugars. A controlled diet of this nature may be particularly impor-
tant during development (Pliss et al, 2016), including throughout
childhood, or to control epilepsy, as has been proposed for PDH
deficiency (Sofou et al, 2017).
Mitochondrial DNA organization and nutrient utilization
The re-organization of the mtDNA and tolerance of a ketone body
growth regime in WHS fibroblasts (Figs 8, 9 and EV3; and
Appendix Figs S8 and S9), and the association of PDH with mito-
chondrial nucleoprotein complexes in both human cells (Fig 8A)
and Xenopus oocytes (Bogenhagen et al, 2003), suggests that the
physical interaction serves a physiological purpose. That is, proteins
determining substrate utilization, such as PDH, act directly on mito-
chondrial nucleoids and ribosomes to couple fuel consumption and
energy production. The mechanism of such coupling may well
involve ion homeostasis that is known to be important for PDH
activity and the TCA cycle in general (Denton et al, 1972; Nichols &
Denton, 1995; Llorente-Folch et al, 2015), and in which LETM1 is
heavily implicated (Nowikovsky et al, 2004; Jiang et al, 2009;
Hashimi et al, 2013; Nowikovsky & Bernardi, 2014; Tsai et al,
2014). Moreover, the strict link between LETM1 and pyruvate
oxidation in mitochondria and increased dependence on alternative
fuels in LETM1-deficient cells may explain why there are contrasting
results relating to mitochondrial dysfunction in WHS (Dimmer et al,
2008; Tamai et al, 2008, and this report).
Mitochondrial DNA organization and energy distribution
A growing number of mitochondrial disorders are now understood
to feature mtDNA aggregation or clustering (Almalki et al, 2014;
Akman et al, 2016; Desai et al, 2017; Nicholls et al, 2018 and this
report). Clustering of the different complexes appears to be remark-
ably well tolerated, in that OXPHOS subunits continue to be
produced and assembled correctly in the vicinity of the mtDNA
aggregates, as respiratory capacity can remain at normal levels
(Appendix Fig S5). Although the failure to distribute mtDNA and its
products throughout the cell need not severely compromise respira-
tory capacity, it can be expected to create problems in tissues such
as muscle and brain, which are those most often affected in mito-
chondrial disorders. Muscle requires a uniform energy supply for
maximal efficiency (Glancy et al, 2015), and to function, neurons
must deliver mitochondrial cargoes to distant synapses. In the case
of mtDNA aggregation and concomitant mitochondrial morphology
defects, the mitochondria for transport could have a dearth of
mtDNA and OXPHOS complexes, which may explain the severe
neurological features in such diseases.
The different outcomes for DRP1 expression in the context of
LETM1 deficiency offer further insights into LETM1’s role and the
architecture of the mtDNA in the organelles. LETM1 deficiency is
associated with mitochondrial distensions, but these are mostly
within the reticular network when DRP1 activity is co-repressed
(LETM1 siR3 and occasionally siR2), whereas when LETM1 is
scarce and DRP1 activity is not repressed, swollen mitochondria are
ubiquitous and the network is fragmented (siR1; Fig 1A). Although
the latter arrangement maintains a near-normal mtDNA distribution
in the face of LETM1 deficiency (Figs 3A and EV1A—siR1), cluster-
ing of the macromolecular complexes might be preferable, to help to
counteract the hypotonic environment, and this could explain the
frequent spontaneous co-repression of DRP1 (Figs 5A and 7E),
which evidently improves mitochondrial translation and OXPHOS
when LETM1 is depleted (Fig 5B and C; and Appendix Fig S3B).
Given that the findings suggest that repressing DRP1 attenuates the
mitochondrial dysfunction caused by LETM1 deficiency, it will be
important to determine whether some cell types of WHS LETM1+/
patients maintain normal levels of DRP1, as, if so, decreasing DRP1
might improve their symptoms or slow disease progression.
Mitochondria are known to adapt physically to nutrient availabil-
ity (Gomes et al, 2011; Rambold et al, 2011). The current study
demonstrates that changes in nutrient availability and utilization
remodel the nucleoprotein complexes in mitochondria and thereby
indicates how nutrients can modulate gene expression and energy
production in the organelle (Fig 9C). An important corollary is that
genetic defects in metabolic factors linked to mitochondrial nucleo-
protein complexes, or their regulators, can produce a pseudo-starva-
tion state, owing to an inability to utilize an available nutrient.
Materials and Methods
Human studies
Informed consent was obtained for all the subjects included in the
study, and the procedures followed were in accordance with the
WMA Declaration of Helsinki and the Department of Health and
Human Services Belmont Report.
Cell lines and culture conditions
Primary skin fibroblasts were obtained from healthy controls
(n = 4) and from Wolf–Hirschhorn syndrome (WHS) patients
(n = 5; Appendix Table S1). Unless stated otherwise, fibroblasts,
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HeLa, and human embryonic kidney cells (HEK293T, Invitrogen)
were grown in Dulbecco’s modified Eagle’s medium (DMEM, Life
Technologies) supplemented with 25 mM glucose, 1 mM pyruvate,
10% fetal bovine serum (FBS, Pan Biotech UK), and 1% penicillin
and streptomycin (PS, Life Technologies) at 37°C in a 5% CO2 atmo-
sphere. All cells were tested for mycoplasma infection on regular
basis using LookOut Mycoplasma PCR Detection Kit (Sigma).
RNA interference of LETM1 and DRP1 in HeLa cells
For knockdown experiments, HeLa cells were transfected using
either siRNAs targeting LETM1 (Appendix Table S2 and
Appendix Fig S1A) or no particular gene (NT). All oligos were trans-
fected at a concentration of 10 nM using Lipofectamine RNAiMAX
(Life Technologies), according to the manufacturer’s specifications.
In general, HeLa cells were analyzed after 6 days, following two
rounds of siRNA with the second transfection performed 3 days
after the first. Where indicated the exceptions were 72 h after one
round of transfection. Simultaneous knockdown of LETM1 and
DRP1 was performed as described above using the siRNA targeting
LETM1 (siR1) and DRP1 (Appendix Table S2).
Cell lysis, SDS–PAGE, Western blotting, and immunodetection
Cells were lysed in PBS, 0.1% n-dodecyl-D-maltoside (DDM,
Sigma), 1% SDS, 50 U benzonase (Novagen), 1:50 (v/v) protease
inhibitor cocktail (Roche), and 1:100 (v/v) phosphatase inhibitor
(Cell Signaling), and protein concentration was measured by Lowry
assay (Bio-Rad). 10–20 lg of proteins was separated by SDS–PAGE
on Bis-Tris NuPAGE gels (Life Technologies) and transferred to
polyvinylidene fluoride membrane (Millipore). Membranes were
blocked in 5% non-fat dry milk in PBS with 0.1% (v/v) Tween-20
(PBST) for 1 h at RT (room temperature) and then incubated over-
night with primary antibodies (Appendix Table S3) at 4°C. The day
after, membranes were washed three times with PBST and incu-
bated for 1 h at RT with the appropriate secondary antibodies.
Membranes were then washed three times with PBST, and signals
were developed using ECL (GE Healthcare).
[35S]-Methionine in cell labeling for mitochondrial
protein synthesis
Mitochondrial translation products were labeled using 35S-methio-
nine as described previously (Dalla Rosa et al, 2014) with some
modifications. Fibroblasts or HeLa cells were washed twice with
methionine-/cysteine-free DMEM (Life Technologies) supplemented
with 1 mM L-GlutaMAX, 96 lg/ml cysteine (Sigma), 1 mM pyruvate,
and 5% (v/v) dialyzed FBS, and incubated in the same medium for
10 min at 37°C. 100 lg/ml emetine dihydrochloride (Sigma) was
then added to inhibit cytosolic translation, before pulse-labeling with
100 lCi [35S]-methionine for 45–60 min. Cell were chased for 10 min
at 37°C in regular DMEM with 10% FBS, washed three times with
PBS, and collected. Labeled cells were lysed in PBS, 0.1% n-dodecyl-
D-maltoside (DDM), 1% SDS, 50 units of benzonase (Novagen), and
1:50 (v/v) Roche protease inhibitor cocktail. Protein concentration
was measured by Lowry assay, and 20 lg of protein was separated
by 12% SDS–PAGE. Gels were dried and exposed to phosphor plates,
and the signal was detected by PhosporImager.
Cellular oxygen consumption
The oxygen consumption rate (OCR) of HeLa cells was assayed with
a XF24 Extracellular Flux Analyzer (Agilent). Briefly, 4 × 104 prolif-
erating cells were seeded in microplates (Agilent) in 250 ll of
prewarmed growth medium (DMEM, Gibco) and incubated 37°C/
5% CO2 for 8 h. Subsequently, the medium was removed and
replaced with assay medium (XF Base minimal DMEM (Agilent)
complemented with 2 mM glucose, 2 mM GlutaMAX, and 1 mM
pyruvate) and cells were incubated for 30 min in a 37°C non-CO2
incubator. After taking an OCR baseline measurement, 1 lM oligo-
mycin, 1.2 lM carbonyl cyanide-4-trifluoromethoxyphenylhydra-
zone (FCCP), and 1 lM rotenone were added sequentially. For
normalization, protein concentration in each well was determined
using the Lowry assay (Bio-Rad).
mtDNA copy number
Quantification of mtDNA was performed as described in Dalla Rosa
et al (2016) with some modifications. Briefly, total DNA was
isolated from frozen pellets of human fibroblasts or HeLa cells using
DNeasy Blood and Tissues Kit (Qiagen), according to the manufac-
turer’ s protocol. Real-time quantitative PCR was performed in tripli-
cate on 384-Well Reaction Plates (Applied Biosystems), in final
volumes of 10 ll. Each reaction contained 20 ng DNA template, 1×
Power SYBR Green PCR Master Mix (Applied Biosystems), and
0.5 lM of forward and reverse primers. Mitochondrial and nuclear
DNAs were amplified using primers specific to regions of human
COXII and APP1 genes, respectively. The sequences of the primers
used are in Appendix Table S2. Changes in mtDNA amount were
calculated using the 2DDCt method (Schmittgen & Livak, 2008) and
represented as fold change relative to the indicated control.
RNA extraction and analysis of mitochondrial transcripts by qPCR
For total RNA extraction, HeLa cells were lysed in TRIzol reagent
(Life Technologies) and RNA, DNA, and proteins were separated by
the addition of chloroform. After centrifugation (15 min, 12,000 g at
4°C), the upper aqueous phase containing RNA was transferred to a
fresh tube and precipitated with equal volume of 70% ethanol. This
solution was then loaded onto a PureLink RNA Mini Kit (Invitrogen)
column, and RNA extraction was completed as per the manufac-
turer’s instruction. Relative transcript abundance was measured by
qPCR on a 7900HT Fast Real-Time PCR System (Applied Biosys-
tems). Transcript levels were normalized to housekeeping transcript
b-2-globulin. Primers are detailed in Appendix Table S2.
Mitochondrial isolation, iodixanol, and sucrose
gradient fractionation
Mitochondria were isolated as previously described (Dalla Rosa
et al, 2014). Briefly, HEK293T cells were disrupted by homogeniza-
tion in hypotonic buffer (20 mM HEPES pH 8, 5 mM KCl, 1.5 mM
MgCl2, and 2 mM DTT) and mixed with a mannitol–sucrose buffer
to final concentration of 210 mM mannitol, 70 mM sucrose, 20 mM
HEPES pH 8, and 2 mM EDTA (1× MSH), prior to purification of
mitochondria by differential centrifugation. For iodixanol gradient
fractionation, 1,000 g supernatant from lysed mitochondria was
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loaded onto 20–42.5% discontinuous iodixanol (OptiPrep, Sigma)
gradients (Dalla Rosa et al, 2014) and centrifuged at 100,000 g for
14 h at 4°C. Resulting gradients were fractionated into 0.5 ml frac-
tions collected from the bottom of the tube and subjected to Western
blot analysis. For the analysis of the mitochondrial ribosome, mito-
chondria were isolated as above using EDTA-free buffers (Dalla
Rosa et al, 2014) and subsequently lysed for 20 min on ice. Two dif-
ferent lysis buffers used were as follows: the standard buffer
containing 260 mM sucrose, 100 mM NaCl, 20 mM MgCl2, 10 mM
Tris–HCl pH 7.5, 1% Triton X-100, 1× protease inhibitor w/o EDTA
(Roche), 0.08 U/ll rRNasin (Promega) in DEPC-treated water and a
second buffer containing a lower concentration of salt (50 mM
NaCl). Mitochondrial lysates were cleared by centrifugation
(10,000 g for 45 min at 4°C) and loaded on 10–30% linear sucrose
gradients made in the appropriate lysis buffer. After centrifugation
at 71,000 g for 15 h at 4°C, 15 fractions of 750 ll each were
collected from the top of the gradient using an automated gradient
harvester (Brandel) and analyzed by Western blotting. In the case of
LETM1 silencing, the isokinetic sucrose gradient analysis of mito-
chondrial ribosomes was performed on total lysates.
Immunofluorescence and imaging
Fibroblasts or HeLa cells grown on coverslips were fixed with 4%
paraformaldehyde, permeabilized with 0.3% Triton X-100, and incu-
bated with indicated primary antibodies (Appendix Table S4) over-
night at 4°C. For bromouridine (BrU) labeling, cells grown on
coverslips were incubated with 5 mM BrU for 60 min prior to fixa-
tion. Anti-BrdU antibody (Appendix Table S4) was used to detect
BrU-labeled RNA. Following washes, cells were incubated for 1 h at
RT with secondary antibody after which coverslips were mounted
on glass slides over ProLong Gold Antifade Reagent, which
includes 40,6-diamidino-2-phenylindole (DAPI). Samples were
imaged either on a SP5 TCS Inverted Confocal Microscope (Leica
Biosystem) using a 63× oil immersion objective with a numerical
aperture of 1.4 (63×/1.4 Oil) or a 100× oil immersion objective with
a numerical aperture of 1.46 (100×/1.46 Oil) or on Nikon Ti
Inverted Confocal Microscope using 60× immersion objective. Z
stack of red, green, and blue images using a step size of either 0.3 or
0.125 lm was acquired sequentially and merged using ImageJ.
Confocal images were adjusted for brightness/contrast in ImageJ.
Images in each figure were processed equally.
Electron microscopy
WHS and control fibroblast cells were fixed in 2% glutaraldehyde/
2% paraformaldehyde for 30 min, and then 1% osmium tetroxide
for 1 h, using 0.1 M sodium cacodylate buffer pH 7.2, at RT. The
samples were then dehydrated and embedded in Epon resin.
Sections were stained with ethanolic uranyl acetate and Reynold’s
lead citrate, and viewed with a JEOL 100EX transmission electron
microscopy (TEM). Images were captured with a Gatan Orius 1000
charge-coupled devices (CCD).
Ketone body supplementation
Fibroblasts were cultured to reach 40–50% confluency, washed
once with PBS (Life Technologies), and incubated with DMEM with
glutamine, w/o glucose and w/o pyruvate (Life Technologies)
supplemented with 0.3 mM b-hydroxybutyrate (BHB, Cayman
Chemical), 10% dialyzed FBS, and 1% PS. The medium was
changed every 48 h. Cell density was determined using an IncuCyte
Live Cell Imaging System (Essen Instruments), and phase-contrast
images were acquired at 3-h intervals over a period of 3 weeks and
processed automatically.
Statistics
All statistical calculations were performed using GraphPad Prism
7.0. Analysis of mitochondrial protein synthesis and immunoblots
was performed using Fiji ImageJ. The non-parametric tests used
were one-way ANOVA or t-test with Welch’s correction. The former
was used to compare more than two independent groups, while the
latter was used to compare two independent groups. All error bars
are  standard error of the mean, which is an estimate of the true
variation of the samples extrapolated from the standard deviation of
the measured values. P-values < 0.05 were considered to be statisti-
cally significant and labeled as follows: *P < 0.05, **P < 0.01, and
***P < 0.001; ns, not statistically significant. Exact P-values are
shown in Appendix Table S5.
Expanded View for this article is available online.
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The paper explained
Problem
The mitochondrial inner membrane protein LETM1 is involved in
regulating ion homeostasis and mitochondrial volume. Yet, consider-
able uncertainty remains around its role in organelle function and
cellular metabolism, and it is not known whether mitochondrial
dysfunction contributes to the pathology in the many cases of Wolf–
Hirschhorn syndrome (WHS) where LETM1 is deficient.
Results
Here, we show that LETM1 is a component of mitochondrial nucleo-
protein complexes that supports mitochondrial translation. The loss of
one copy of LETM1 produces aberrant mitochondrial morphology and
DNA disorganization in WHS LETM1+/ fibroblasts, phenocopying
LETM1 gene silencing. The effect on mtDNA is associated with remod-
eling of nutrient metabolism toward ketone body utilization.
Impact
The findings establish roles for LETM1 in mitochondrial gene expres-
sion and mtDNA organization and show that LETM1 insufficiency
causes mitochondrial abnormalities in WHS. Moreover, the results
show that the arrangement of mitochondrial nucleoids and ribosomes
is tied to nutrient availability and if incorrectly configured, nutrient
usage by the mitochondria is no longer matched to availability, which
can result in impaired organelle function and disease.
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